Literature DB >> 14993071

Corticosteroid receptor transgenic mice: models for depression?

Alexandre Urani1, Peter Gass.   

Abstract

Dysregulations and dysfunctions of corticosteroids and their receptors have been implicated in the pathogenesis of stress-related disorders, in particular in depression. It is currently under debate, however, whether corticosteroid imbalances are a cause or rather a consequence of affective disorders. Corticosteroids exert their effects mainly by two receptors: glucocorticoid receptors (GRs) and mineralocorticoid receptors (MRs). We present here analyses made on several strains of mice with targeted mutations of corticosteroid receptors. The results help to understand how corticosteroid receptors regulate the hypothalamic-pituitary-adrenal (HPA) system. Furthermore, first behavioral analyses have indicated that corticosteroid receptor mutant mice show alterations in their emotional behavior. Certain mouse strains with specific alterations of GR or MR expression may represent genetic models of depression or at least have a predisposition to develop a depressive or a depression-resistant state upon exposure to stress. The corticosteroid receptor-regulated target genes to be identified in these models may code for proteins that could represent new drug-targets for the treatment of affective disorders.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14993071     DOI: 10.1196/annals.1286.037

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  7 in total

Review 1.  Modeling human neurodegenerative diseases in transgenic systems.

Authors:  Miguel A Gama Sosa; Rita De Gasperi; Gregory A Elder
Journal:  Hum Genet       Date:  2011-12-14       Impact factor: 4.132

Review 2.  Behavioral insights from mouse models of forebrain--and amygdala-specific glucocorticoid receptor genetic disruption.

Authors:  Melinda G Arnett; Benedict J Kolber; Maureen P Boyle; Louis J Muglia
Journal:  Mol Cell Endocrinol       Date:  2010-11-20       Impact factor: 4.102

3.  Modulation of glucocorticoid receptor nuclear translocation in neurons by immunophilins FKBP51 and FKBP52: implications for major depressive disorder.

Authors:  Erick T Tatro; Ian P Everall; Marcus Kaul; Cristian L Achim
Journal:  Brain Res       Date:  2009-06-21       Impact factor: 3.252

4.  FKBP5 moderation of depressive symptoms in peer victimized, post-institutionalized children.

Authors:  Adrienne A VanZomeren-Dohm; Clio E Pitula; Kalsea J Koss; Kathleen Thomas; Megan R Gunnar
Journal:  Psychoneuroendocrinology       Date:  2014-10-13       Impact factor: 4.905

5.  The effects of CRF antagonists, antalarmin, CP154,526, LWH234, and R121919, in the forced swim test and on swim-induced increases in adrenocorticotropin in rats.

Authors:  Emily M Jutkiewicz; Susan K Wood; Hani Houshyar; Ling-Wei Hsin; Kenner C Rice; James H Woods
Journal:  Psychopharmacology (Berl)       Date:  2005-02-05       Impact factor: 4.530

6.  Antidepressant-like behavioral, anatomical, and biochemical effects of petroleum ether extract from maca (Lepidium meyenii) in mice exposed to chronic unpredictable mild stress.

Authors:  Zhong Ai; Ai-Fang Cheng; Yuan-Tao Yu; Long-Jiang Yu; Wenwen Jin
Journal:  J Med Food       Date:  2014-04-14       Impact factor: 2.786

7.  A novel 2-decenoic acid thioester ameliorates corticosterone-induced depression- and anxiety-like behaviors and normalizes reduced hippocampal signal transduction in treated mice.

Authors:  Shoyo Shibata; Munekazu Iinuma; Hitomi Soumiya; Hidefumi Fukumitsu; Yoshiko Furukawa; Shoei Furukawa
Journal:  Pharmacol Res Perspect       Date:  2015-03-25
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.